Copyright
©The Author(s) 2021.
World J Gastroenterol. Dec 7, 2021; 27(45): 7831-7843
Published online Dec 7, 2021. doi: 10.3748/wjg.v27.i45.7831
Published online Dec 7, 2021. doi: 10.3748/wjg.v27.i45.7831
Figure 1 Data on admissions in the United States due to hepatorenal syndrome.
A: Decreasing trend in hospital mortality among hospital admissions; B: Increase in the rate of liver transplantation among hospital admissions; C: Trend of renal replacement therapy among hospital admissions; D: Trend of mean length of hospital stay among hospital admissions; E: Trend of hospitalization cost among hospital admissions. NIS: National inpatient sample.
- Citation: Kaewput W, Thongprayoon C, Dumancas CY, Kanduri SR, Kovvuru K, Kaewput C, Pattharanitima P, Petnak T, Lertjitbanjong P, Boonpheng B, Wijarnpreecha K, Zabala Genovez JL, Vallabhajosyula S, Jadlowiec CC, Qureshi F, Cheungpasitporn W. In-hospital mortality of hepatorenal syndrome in the United States: Nationwide inpatient sample. World J Gastroenterol 2021; 27(45): 7831-7843
- URL: https://www.wjgnet.com/1007-9327/full/v27/i45/7831.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i45.7831